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Abstract
• Deaths related to opioid overdose has been an increasing problem in the United States
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• Deaths related to opioid overdoses can be prevented by the use of naloxone which reverses the effects of
opioids
• Approaches to promote naloxone access have been described by federal agencies, including the
Substance Abuse and Mental Health Services Administration
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METHODS
Using national and state databases, 
information was collected and analyzed 
for each state regarding the following: 
• Requirements of concurrently 
prescribing naloxone with opioid 
prescriptions
• Naloxone access in community 
pharmacies
• Layperson access to naloxone without 
a prescription
Evaluating Naloxone Access and Prescribing Requirements in the 
Opioid Epidemic across the United States
Dr. Krista Brooks, Dr. Tom Davis, Khoa Nguyen, Ngan-Dinh Nguyen, Tashrique Rahman, Lucero Villa
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INTRODUCTION
• Deaths related to opioid overdose has 
been an increasing problem in the 
United States
• Deaths related to opioid overdoses can 
be prevented by the use of naloxone 
which reverses the effects of opioids
• Approaches to promote naloxone 
access have been described by federal 
agencies, including the Substance 
Abuse and Mental Health Services 
Administration
OBJECTIVES
• The primary objective of this study is to 
examine naloxone access in 
community pharmacies for each state
• Secondary objectives include which 
states require physicians to prescribe 
naloxone to patients receiving opioids, 
and layperson access to naloxone
AUTHOR DISCLOSURE
Authors of this presentation have nothing to disclose concerning possible 
financial or personal  relationships with commercial entities that may have 
a direct or indirect  interest in the subject matter of this presentation.
RESULTS
• New state laws have expand access to 
naloxone without a patient-specific 
prescription
• All community pharmacies have 
increased access to naloxone through 
state policies such as
• Standing orders
• Protocol orders
• Pharmacists Prescriptive Authority
• Collaborative Practice Agreements
• Only 5 states require prescribers to 
provide a naloxone prescription along 
with an opioid prescription
• Several states have implemented 
programs that provide intra-nasal 
naloxone outside of pharmacies
• The majority of states have passed 
Good Samaritan Laws
STATE SPECIFIC INFORMATION AND DEFINITIONS
REFERENCES
Prescription Drug Abuse Policy System. (2017). Naloxone Overdose Prevention Laws. 2017, from http://pdaps.org/dataset/overview/laws-regulating-administration-of- naloxone/5977b661d42e07f31dcafb6e 
Preventing the Consequences of Opioid Overdose: Understanding Naloxone Access Laws, from https://www.samhsa.gov/capt/sites/default/files/resources/naloxone-access-laws-tool.pdf
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CONCLUSION and 
FUTURE IMPLICATIONS
• Changing laws have helped make 
naloxone easier for people to access 
this life-saving medication by 
increasing how it can be distributed 
beyond traditional prescriptions.  
Increased access allows individuals at 
risk, as well as friends and families of 
those at risk, be prepared in the event 
of an opioid overdose
• As the removal of barriers are making it 
easier for individuals to obtain 
naloxone, it is important that 
pharmacists are able to help provide 
risk identification and administration 
education to the public
Laws that provide immunity from arrest, 
charge or prosecution for certain controlled 
substance possession and paraphernalia 
offenses when a person who is either 
experiencing an opiate-related overdose or 
observing one calls 911 for assistance or 
seeks medical attention
Required Naloxone  
Co-Prescriptions
States that require practitioners 
to co-prescribe naloxone with 
opioids:
Ø Arizona *
Ø Colorado **
Ø Rhode Island *, **, ***
Ø Virginia *, **, ***
Ø Washington **
*Dependent upon opioid amount
**High Risk Patients
***Patient is also taking a benzodiazepine
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State Policies
Protocol orders:
KS, SC, WV
Protocol orders & Pharmacist 
prescriptive authority:
OR
Pharmacist prescriptive 
authority:
CT, ID, OK
Standing orders:
AL, AR, CO, DE, FL, GA, IN, KT, LA, MD, MA, MI, 
MN, MO, NH, NJ, NY, NC, PA, RI, SD, TX, UT, WI 
Standing orders & 
Collaborative practice 
agreements:
HI, IA, MT, WA
Standing orders & Protocol 
orders:
AK, AZ, CA, IL, NV, OH, VT, VA
Standing orders, Protocol 
orders, & Collaborative 
practice agreements:
MN, TN
Standing orders & Pharmacist 
prescriptive authority:
NM, ND, WY
Many states have passed legislation that allows non-medical professionals to 
distribute naloxone within community settings (outside of pharmacies) even if 
they are not otherwise permitted to distribute prescription medications 
Standing orders - Written by prescribers, these orders authorize pharmacies to dispense naloxone to 
patients without a prescription from a provider. 
Protocol orders. These are similar to a standing order except the authorization to dispense naloxone 
comes from a state board of health or pharmacy licensing board instead of a licensed prescriber 
Collaborative practice agreements. These are another type of formal agreement between prescribers 
and specific pharmacies or pharmacy chains within a state. Like standing and protocol orders, they permit 
the pharmacist to dispense naloxone without the patient first seeing a prescriber. 
Pharmacist prescriptive authority. This approach allows pharmacists to prescribe naloxone without an 
order or agreement from a physician, pharmaceutical board, or board of health. 
Arizona Missouri
Idaho Oklahoma
Iowa South Carolina
Kansas Texas
Maine Wyoming
6%
2%
6%
50%
8%
16%
4%
8%
Naloxone Access In 
Community 
Pharmacies
PO
PO, PPA
PPA
SO
SO, CPA
SO, PO
SO, PO, CPA
SO, PPA
Examples of States with Layperson Access:
Community Distribution sites (Hubs)
OK, RI, VT
Emergency Stations (along with AEDs)
DE, RI, VA
Health Departments
IL, IN, MD, MA, NH, NJ, VA
Layperson Access To Intra-nasal Naloxone (NARCAN®)
Good Samaritan Laws
Non-patient Specific Prescriptions in Pharmacies
States without Good Samaritan LawsStates with Good Samaritan Laws
